Rhythm Pharmaceuticals, Inc. Insider Trading Activity
Accepted by SEC EDGAR
Learn about SEC filing dates
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Insider Trade Summary
Exercise and sale activity reported; no spread calculated
Exercise and Sale
6 txns
Insider
German Christopher Paul
Role
Corporate Controller & CAO
Sold
3,817 shs ($308K)
Approx. gross sale proceeds
$308K
Approx. exercise cost
$78K
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Options (Right to Buy) | 2,000 | $0.00 | $0.00 |
| Exercise | Stock Options (Right to Buy) | 850 | $0.00 | $0.00 |
| Exercise | Common Stock | 2,000 | $17.97 | $36K |
| Exercise | Common Stock | 850 | $49.23 | $42K |
| Sale | Common Stock | 1,967 | $76.75 | $151K |
| Sale | Common Stock | 1,850 | $85.00 | $157K |
Holdings After Transaction:
Stock Options (Right to Buy) — 10,781 options (Direct);
Common Stock — 922 shares (Direct)
Footnotes (3)
- F1. The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 11, 2025.
- F2. The stock options were granted on April 4, 2023. The options vest and become exercisable as to 25% of the total shares on March 20, 2024 and, thereafter, as to the remaining 75% of the total shares in twelve equal quarterly installments of 6.25% beginning June 20, 2024 and ending March 20, 2027, subject to the Reporting Person's continued service on each such vesting date.
- F3. The stock options were granted on February 16, 2024. The options vest and become exercisable in 16 substantially equal installments upon the Reporting Person's completion of each three full months of successive service to the Issuer following the grant date.
AI-generated analysis. How Rhea-AI works. Not financial advice.